Resources for You
Roster of the Cellular, Tissue and Gene Therapies Advisory Committee
As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.
Current Number of Vacancies: 2
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.
- Designated Federal Officer
Janie Kim, Pharm.D.
Division Of Scientific Advisors And Consultants
Center For Biologics Evaluation And Research
- James R. Anderson, Ph.D.
Term: 04/01/2014 – 03/31/2018
Managing Director, Madison Office
Frontier Science and Technology Research Foundation
Dale Ando, M.D.*
Expertise: Industry Representative
Term: 4/1/2015 – 3/31/2019
Vice President, Therapeutic Development and Chief Medical Officer
Sangamo Biosciences, Inc.
David L. Bartlett, M.D.
Expertise: Surgical Oncology
Director, Surgical Services for UPCI
University of Pittsburgh Department of Surgery
- William D. Bugbee, M.D.
Expertise: Orthopaedic Surgery/Tissue Transplantation
Attending Orthopaedic Surgeon
Division of Orthopaedic Surgery
10666 North Torrey Pines Road
La Jolla, CA 92037
Barry J. Byrne, M.D., Ph.D.
Expertise: Molecular Genetics/Pediatrics/Microbiology
Term: 4/1/2014 – 3/31/2018
Pediatrics and Molecular Genetics and Microbiology
Powell Gene Therapy Center
University of Florida College of Medicine
- Timothy P. Cripe, M.D., Ph.D.
Expertise: Pediatric Hematology/Oncology
Division of Hematology/Oncology/Bone Marrow Transplantation
Nationwide Children’s Hospital
The Ohio State University Wexner College of Medicine
700 Children’s Drive
Columbus, Ohio 43205
- Leisha A. Emens, M.D., Ph.D.
Expertise: Oncology/Cancer Vaccines
Term: 04/01/2012 - 03/31/2016
Associate Professor of Oncology
Johns Hopkins University School of Medicine
1650 Orleans Street, Room 409
Baltimore, MD 21231
- John D. Gearhart, Ph.D.
Expertise: Stem Cell Biology/Cellular Therapies
Term: 01/06/2012 - 03/31/2016
James Effron University Professor
Institute for Regenerative Medicine
University of Pennsylvania School of Medicine
Biomedical Research Building
421 Curie Blvd., 1150
Philadelphia, PA 19104
- Ole Isacson, M.D.-Ph.D.
Expertise: Neurology and Neuroscience
Term: 10/21/14 - 3/31/2018
Professor of Neurology and Neuroscience
Director of the Neuroregeneration Institute and Neuroregeneration Laboratory
McLean Hospital/ Harvard Medical School
Grace E. Pluhar, D.V.M., Ph.D., Diplomate ACVS
Expertise: Veterinary Medicine
Term: 04/01/2014 – 3/31/2018
College of Veterinary Medicine
University of Minnesota
St. Paul, Minnesota
- Stephen M. Rose, Ph.D.**
Expertise: Translational Research
Term: 04/11/2012 - 03/31/2016
Chief Research Officer
Foundation Fighting Blindness
7168 Columbia Gateway Drive
Columbia, MD 21046
Robert F. Willenbucher, M.D., M.B.A.***
Expertise: Regenerative Medicine and Cell Therapy
Term: 04/01/2013 – 3/31/2017
Head of Cell Therapy and the Janssen Incubator
Janssen Research & Development, LLC
Spring House, Pennsylvania
Ann C. Zovein, M.D.
Expertise: Stem Cell/Developmental Biology/ Regenerative Medicine
Term: 04/01/2014 – 03/31/2018
University of California San-Francisco
Cardiovascular Research Institute
Division of Neonatology, Department of Pediatrics
San Francisco, California
* Industry Representative
** Consumer Representative
*** Alternate Industry Representative